Status:
COMPLETED
Administration of Human Chorionic Gonadotrophin Before Secretory Transformation of Frozen-thawed Embryo Transfer Cycles
Lead Sponsor:
Alexandria University
Conditions:
hCG
FET
Eligibility:
FEMALE
18-38 years
Phase:
PHASE4
Brief Summary
Successful embryo implantation is complicated process that requires synchrony between good-quality embryos and receptive endometrium. Human chorionic gonadotropin (hCG), is one of the initial embryoni...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient age ≤ 38 years.
- Normal 3D transvaginal ultrasound.
- At least two good quality embryos cryopreserved by vitrification.
- No GnRH agonists administration before FET cycle.
- Exclusion Criteria
- Endometriosis.
- Uterine anomalies.
- Evidence of hydrosalpinx by hystrosalpingography or ultrasound.
- Evidence of immune disease, hematological or hormonal disorder.
Exclusion
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT05340010
Start Date
January 1 2020
End Date
July 30 2022
Last Update
September 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria university
Alexandria, Egypt